NASDAQ:MYGN Investor Notice: Lawsuit Alleges Misleading Statements by Myriad Genetics, Inc.
October 18, 2019 at 12:45 PM EDT
San Diego, CA -- (SBWIRE) -- 10/18/2019 -- An investor, who purchased shares of Myriad Genetics, Inc. (NASDAQ: MYGN), filed a lawsuit over alleged violations of Federal Securities Laws by Myriad Genetics, Inc.